Share on
HTML EMBED
Click to Copy
Marketplace Morning Report

Phishing for the greater good

May 22, 2019

Latest Episodes

Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy
Make Me Smart with Kai and Molly
Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Marketplace Tech
Share on
HTML EMBED
Click to Copy

Here’s why Eli Lilly will sell a generic insulin

Marielle Segarra Mar 4, 2019
Share Now on:
HTML EMBED:
COPY

Indianapolis-based pharmaceutical company Eli Lilly announced Monday that it will sell a generic version of Humalog, its branded insulin product. The generic will cost $137 per vial, or half as much as Humalog. Lilly’s move is seen as a partial concession to lawmakers who have grilled pharma companies about the high cost of life-saving prescription drugs. But the company will keep Humalog at its current price. Why this two-tiered drug strategy?

Click the audio player above to hear the full story.

How We Survive
How We Survive
Climate change is here. Experts say we need to adapt. This series explores the role of technology in helping humanity weather the changes ahead.